Founded through the University of Pennsylvania’s Y-Prize program in 2017, Avisi Technologies develops nanotechnology-enabled ophthalmic devices for glaucoma, including its investigational VisiPlate aqueous shunt. The Redwood City company combines materials science, ophthalmology and MEMS microfabrication to create ultrathin implants intended to lower eye pressure, while its VisiPlate technology advances through clinical research.